The FDA issued three draft guidance documents applying to compounding pharmacies, hospitals, and outsourcing facilities. The guidance aims to clarify prescription requirements, how 503A applies to hospital pharmacies, and the definition of "facility" in 503B. Stakeholders have 90 days to provide feedback. The guidance restricts compounding pharmacies to filling individual prescriptions but allows in-house hospital pharmacies to distribute without prescriptions within 1 mile. It also narrows the definition of "facility" to mean a single operation within one building. Proposed legislation could contradict the FDA's policies by allowing compounding without individual prescriptions.